Junyu Chen

Mr. Junyu Chen

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Cell Reports
Verified
Journal Article
Open access
JKJanise Kuehner
Janise Kuehner
JCJunyu Chen
Junyu Chen
EBEmily C. Bruggeman
Emily C. Bruggeman
FWFeng Wang
Feng Wang
YLYangping Li
Yangping Li
BYBing Yao
Bing Yao
5-hydroxymethylcytosine (5hmC) undergoes dynamic changes during mammalian brain development, and its dysregulation is associated with Alzheimer's disease (AD). The dynamics of 5hmC during early human brain development and how they contribute to AD pathologies remain largely unexplored. We generate 5hmC and transcriptome profiles encompassing several developmental time points of healthy forebrain organoids and organoids derived from several familial AD patients. Stage-specific differentially hydroxymethylated regions demonstrate an acquisition or depletion of 5hmC modifications across developmental stages. Additionally, genes concomitantly increasing or decreasing in 5hmC and gene expression are enriched in neurobiological or early developmental processes, respectively. Importantly, our AD organoids corroborate cellular and molecular phenotypes previously observed in human AD brains. 5hmC is significantly altered in developmentally programmed 5hmC intragenic regions in defined fetal histone marks and enhancers in AD organoids. These data suggest a highly coordinated molecular system that may be dysregulated in these early developing AD organoids.

29 March 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YXYanyan Xing
Yanyan Xing
JCJunyu Chen
Junyu Chen
HHHenry Hilley
Henry Hilley
HSHaley Steele
Haley Steele
JYJingjing Yang
Jingjing Yang
LHLiang Han
Liang Han

20 March 2019 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JCJunyu Chen
Junyu Chen
YHYunfeng Huang
Yunfeng Huang
QHQin Hui
Qin Hui
RMRaina Mathur
Raina Mathur
MGMarta Gwinn
Marta Gwinn
YSYan Sun
Yan Sun
People living with human immunodeficiency virus (HIV) infection have higher risk for chronic kidney disease (CKD), defined by a reduced estimated glomerular filtration rate (eGFR). Previous studies have implicated epigenetic changes related to CKD; however, the mechanism of HIV-related CKD has not been thoroughly investigated. We conducted an epigenome-wide association study of eGFR among 567 HIV-positive and 117 HIV-negative male participants in the Veterans Aging Cohort Study to identify epigenetic signatures of kidney function. By surveying more than 400 000 cytosine guanine dinucleotide (CpG) sites measured from peripheral blood mononuclear cells, we identified 15 sites that were significantly associated with eGFR (false discovery rate Q value < 0.05) among HIV-positive participants. The most significant CpG sites, located at MAD1L1, TSNARE1/BAI1, and LTV1, were all negatively associated with eGFR (cg06329547, P = 5.25 × 10–9; cg23281907, P = 1.37 × 10–8; cg18368637, P = 5.17 × 10–8). We also replicated previously reported eGFR-associated CpG sites including cg17944885 (P = 2.5 × 10–5) located between ZNF788 and ZNF20 on chromosome 19 in the pooled population. In this study we uncovered novel epigenetic associations with kidney function among people living with HIV and suggest potential epigenetic mechanisms linked with HIV-related CKD risk.

2 May 2022 in Allergy
Verified
Journal Article
Open access
AKAnna Kilanowski
Anna Kilanowski
JCJunyu Chen
Junyu Chen
TETodd Everson
Todd Everson
ETElisabeth Thiering
Elisabeth Thiering
RWRory Wilson
Rory Wilson
AHAnke Huels
Anke Huels
Background: Epigenomic (e.g., DNA methylation [DNAm]) changes have been hypothesized as intermediate step linking environmental exposures with allergic disease. Associations between individual DNAm at CpGs and allergic diseases have been reported, but their joint predictive capability is unknown.Methods: Data were obtained from 240 children of the German LISA cohort. DNAm was measured in blood clots at 6 (N = 234) and 10 years (N = 227) using the Illumina EPIC chip. Presence of aeroallergen sensitization was measured in blood at 6, 10, and 15 years. We calculated six methylation risk scores (MRS) for allergy‐related phenotypes, like total and specific IgE, asthma, or any allergies, based on available publications and assessed their performances both cross‐sectionally (biomarker) and prospectively (predictor of the disease). Dose–response associations between aeroallergen sensitization and MRS were evaluated.Results: All six allergy‐related MRS were highly correlated (r > .86), and seven CpGs were included in more than one MRS. Cross‐sectionally, we observed an 81% increased risk for aeroallergen sensitization at 6 years with an increased MRS by one standard deviation (best‐performing MRS, 95% confidence interval = [43%; 227%]). Significant associations were also seen cross‐sectionally at 10 years and prospectively, though the effect of the latter was attenuated when restricted to participants not sensitized at baseline. A clear dose–response relationship with levels of aeroallergen sensitization could be established cross‐sectionally, but not prospectively.Conclusion: We found good classification and prediction capabilities of calculated allergy‐related MRS cross‐sectionally, underlining the relevance of altered gene‐regulation in allergic diseases and providing insights into potential DNAm biomarkers of aeroallergen sensitization.

6 July 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
CLChang Liu
Chang Liu
ZWZicheng Wang
Zicheng Wang
QHQin Hui
Qin Hui
YCYiyun Chiang
Yiyun Chiang
JCJunyu Chen
Junyu Chen
YSYan Sun
Yan Sun
Genome-wide association studies (GWAS) of circulating metabolites have revealed the role of genetic regulation on the human metabolome. Most previous investigations focused on European ancestry, and few studies have been conducted among populations of African descent living in Africa, where the infectious disease burden is high (e.g., human immunodeficiency virus (HIV)). It is important to understand the genetic associations of the metabolome in diverse at-risk populations including people with HIV (PWH) living in Africa. After a thorough literature review, the reported significant gene–metabolite associations were tested among 490 PWH in South Africa. Linear regression was used to test associations between the candidate metabolites and genetic variants. GWAS of 154 plasma metabolites were performed to identify novel genetic associations. Among the 29 gene–metabolite associations identified in the literature, we replicated 10 in South Africans with HIV. The UGT1A cluster was associated with plasma levels of biliverdin and bilirubin; SLC16A9 and CPS1 were associated with carnitine and creatine, respectively. We also identified 22 genetic associations with metabolites using a genome-wide significance threshold (p-value < 5 × 10−8). In a GWAS of plasma metabolites in South African PWH, we replicated reported genetic associations across ancestries, and identified novel genetic associations using a metabolomics approach.

14 May 2025 in Genes
Verified
Journal Article
Open access
PDF file
JCJunyu Chen
Junyu Chen
MEMichael P. Epstein
Michael P. Epstein
JSJoellen M. Schildkraut
Joellen M. Schildkraut
SKSiddhartha P. Kar
Siddhartha P. Kar
Background: Germline alleles near genes encoding certain immune checkpoints (CTLA4, CD200) are associated with autoimmune/autoinflammatory disease and cancer, but in opposite ways. This motivates a systematic search for additional germline alleles with this pattern with the aim of identifying potential cancer immunotherapeutic targets using human genetics. Methods: Pairwise fixed effect cross-disorder meta-analyses combining genome-wide association studies (GWAS) for breast, prostate, ovarian and endometrial cancers (240,540 cases/317,000 controls) and seven autoimmune/autoinflammatory diseases (112,631 cases/895,386 controls) coupled with in silico follow-up. Results: Meta-analyses followed by linkage disequilibrium clumping identified 312 unique, independent lead variants with p < 5 × 10−8 associated with at least one of the cancer types at p < 10−3 and one of the autoimmune/autoinflammatory diseases at p < 10−3. At each lead variant, the allele that conferred autoimmune/autoinflammatory disease risk was protective for cancer. Mapping led variants to nearest genes as putative functional targets and focusing on immune-related genes implicated 32 genes. Tumor bulk RNA-Seq data highlighted that the tumor expression of 5/32 genes (IRF1, IKZF1, SPI1, SH2B3, LAT) was each strongly correlated (Spearman’s ρ > 0.5) with at least one intra-tumor T/myeloid cell infiltration marker (CD4, CD8A, CD11B, CD45) in every one of the cancer types. Tumor single-cell RNA-Seq data from all cancer types showed that the five genes were more likely to be expressed in intra-tumor immune versus malignant cells. The five lead SNPs corresponding to these genes were linked to them via the expression of quantitative trait locus mechanisms and at least one additional line of functional evidence. Proteins encoded by the genes were predicted to be druggable. Conclusions: We provide population-scale germline genetic and functional genomic evidence to support further evaluation of the proteins encoded by IRF1, IKZF1, SPI1, SH2B3 and LAT as possible targets for cancer immunotherapy.